Cargando…

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction

The physiological role of the renin angiotensin aldosterone system (RAAS) is to maintain the integrity of the cardiovascular system. The effect of angiotensin II is mediated via the angiotensin type I receptor (AT1) resulting in vasoconstriction, sodium retention and myocyte growth changes. This cau...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bissessor, Naylin, White, Harvey
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291334/ https://www.ncbi.nlm.nih.gov/pubmed/17969373

Ejemplares similares

A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction
por: Zhou, Xiaomin, et al.
Publicado: (2022)

Sacubitril/valsartan averts post-myocardial infarction ventricular remodeling and preserves heart function
por: Hajra, Adrija, et al.
Publicado: (2019)

Diagnosis and Treatment of Asymptomatic Left Ventricular Systolic Dysfunction after Myocardial Infarction
por: Ajello, Laura, et al.
Publicado: (2013)

Heart Failure After Right Ventricular Myocardial Infarction
por: Nägele, Matthias P., et al.
Publicado: (2022)

Heart Failure with Preserved Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Antonelli, Lucas, et al.
Publicado: (2015)

Transient left ventricular systolic dysfunction mimicking myocardial infarction after pericardiocentesis
por: Weijers, R. W. J. H., et al.
Publicado: (2013)

Prognostic impact of incident left ventricular systolic dysfunction after myocardial infarction
por: Yoshioka, Goro, et al.
Publicado: (2022)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Tetrandrine attenuates left ventricular dysfunction in rats with myocardial infarction
por: Wu, Youyang, et al.
Publicado: (2021)

Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)

Effects of Sacubitril/Valsartan Treatment on Left Ventricular Myocardial Torsion Mechanics in Patients with Heart Failure Reduced Ejection Fraction 2D Speckle Tracking Echocardiography
por: Elshafey, Wassam Eldin Hadad, et al.
Publicado: (2021)

Incidence of Atrial Fibrillation in Patients with either Heart Failure or Acute Myocardial Infarction and Left Ventricular Dysfunction: A Cohort Study
por: Schmiegelow, Michelle D, et al.
Publicado: (2011)

Predicting Outcomes Over Time in Patients With Heart Failure, Left Ventricular Systolic Dysfunction, or Both Following Acute Myocardial Infarction
por: Lopes, Renato D., et al.
Publicado: (2016)

Sacubitril/valsartan in the treatment of systemic right ventricular failure
por: Zandstra, Tjitske E, et al.
Publicado: (2021)

Efficacy and safety of sacubitril valsartan in treating heart failure with midrange ejection fraction after acute myocardial infarction in diabetic patients
por: Ye, Fanhao, et al.
Publicado: (2022)

Effects of valsartan on ventricular arrhythmia induced by programmed electrical stimulation in rats with myocardial infarction
por: Jiao, Kun-Li, et al.
Publicado: (2012)

Improving medication optimisation in left ventricular systolic dysfunction after acute myocardial infarction
por: Forsyth, Paul, et al.
Publicado: (2019)

Sacubitril/Valsartan in the Treatment of Right Ventricular Dysfunction in Patients With Heart Failure With Reduced Ejection Fraction: A Real-world Study
por: Yang, Ying, et al.
Publicado: (2022)

Optimal Timing of Surgical Revascularization for Myocardial Infarction and Left Ventricular Dysfunction
por: Wang, Rong, et al.
Publicado: (2017)

Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
por: Docherty, Kieran F., et al.
Publicado: (2021)

Left Ventricular Remodeling after Myocardial Infarction: From Physiopathology to Treatment
por: Leancă, Sabina Andreea, et al.
Publicado: (2022)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction
por: Tang, Xian-Liang, et al.
Publicado: (2011)

Sacubitril/Valsartan Improves Left Atrial and Ventricular Strain and Strain Rate in Patients with Heart Failure with Reduced Ejection Fraction
por: Brás, Pedro Garcia, et al.
Publicado: (2023)

Predictors of Recovery of Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: From the Korean Acute Myocardial Infarction Registry and Korean Myocardial Infarction Registry
por: Oh, Pyung Chun, et al.
Publicado: (2013)

The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling
por: Park, Kyungil, et al.
Publicado: (2018)

Hyperglycemia can delay left ventricular dysfunction but not autonomic damage after myocardial infarction in rodents
por: Rodrigues, Bruno, et al.
Publicado: (2011)

Improving Left Ventricular Myocardial Function After Myocardial Infarction: Is it in the BAG?
por: McTiernan, Charles F.
Publicado: (2016)

Left Ventricular Remodeling and Heart Failure Predictors in Acute Myocardial Infarction Patients with Preserved Left Ventricular Ejection Fraction after Successful Percutaneous Intervention in Western Romania
por: Arnautu, Diana-Aurora, et al.
Publicado: (2022)

Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures
por: Brandt, Eric J., et al.
Publicado: (2020)

Transfer RNA-derived small RNAs and their potential roles in the therapeutic heterogeneity of sacubitril/valsartan in heart failure patients after acute myocardial infarction
por: Su, Jia, et al.
Publicado: (2022)

Left ventricular dysfunction in atrial fibrillation and heart failure risk
por: Kuo, Jen‐Yuan, et al.
Publicado: (2020)

Unrecognized concomitant ventricular septal rupture and left ventricular aneurysm 10 months after myocardial infarction in a patient presenting with chronic heart failure
por: Kawamura, Masashi, et al.
Publicado: (2021)

Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
por: Huitema, Ashlay A., et al.
Publicado: (2020)

Progression of Left Ventricular Pseudoaneurysm after an Acute Myocardial Infarction
por: Kim, Mi-Na, et al.
Publicado: (2010)

Left ventricular thrombus formation after acute myocardial infarction
por: Delewi, Ronak, et al.
Publicado: (2012)

Short-term diabetes attenuates left ventricular dysfunction and mortality rates after myocardial infarction in rodents
por: Rodrigues, Bruno, et al.
Publicado: (2011)

TNF-Like Weak Inducer of Apoptosis Aggravates Left Ventricular Dysfunction after Myocardial Infarction in Mice
por: Jarr, Kai-Uwe, et al.
Publicado: (2014)

Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction
por: Hamilton, Eleonora, et al.
Publicado: (2023)

The duration of beta‐blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study
por: Wen, Xue‐Song, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mne27u0j2flpjmm4v86cpvf3q6